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ABSTRACT
Objectives: Medical tourism involves patients’
intentional travel to privately obtain medical care in
another country. Empirical evidence regarding
health and safety risks facing medical tourists is
limited. Consideration of this issue is dominated
by speculation and lacks meaningful input from
people with specific expertise in patient health and
safety. We consulted with patient health and safety
experts in the Canadian province of British
Columbia to explore their views concerning risks
that medical tourists may be exposed to. Herein,
we report on the findings, linking them to existing
ethical and legal issues associated with medical
tourism.
Design: We held a focus group in September
2011 in Vancouver, British Columbia with
professionals representing different domains of
patient health and safety expertise. The focus
group was transcribed verbatim and analysed
thematically.
Participants: Seven professionals representing the
domains of tissue banking, blood safety, health
records, organ transplantation, dental care, clinical
ethics and infection control participated.
Results: Five dominant health and safety risks for
outbound medical tourists were identified by
participants: (1) complications; (2) specific
concerns regarding organ transplantation;
(3) transmission of antibiotic-resistant organisms;
(4) (dis)continuity of medical documentation and
(5) (un)informed decision-making.
Conclusions: Concern was expressed that medical
tourism might have unintended and undesired
effects upon patients’ home healthcare systems.
The individual choices of medical tourists could
have significant public consequences if healthcare
facilities in their home countries must expend
resources treating postoperative complications.
Participants also expressed concern that medical
tourists returning home with infections, particularly
antibiotic-resistant infections, could place others at
risk of exposure to infections that are refractory to
standard treatment regimens and thereby pose
significant public health risks.
ARTICLE SUMMARY
Article focus
▪ Medical tourism involves patients’ intentional
travel to privately obtain medical care abroad.
▪ Empirical evidence regarding the health and safety
risks facing medical tourists is limited, highly
speculative and lacks meaningful input from people
with specific expertise in patient health and safety.
▪ In 2011, a focus group was held with patient health
and safety experts to explore their views concerning
risks that Canadian medical tourists may be exposed
to in purchasing private medical care abroad.
Key messages
▪ The individual choices of medical tourists could
have significant public consequences if healthcare
facilities in their home countries must expend
resources treating postoperative complications.
▪ Medical tourists returning home with infections,
particularly antibiotic-resistant infections, could
place others at risk of exposure to infections that
are refractory to standard treatment regimens
and thereby pose significant public health risks.
▪ Limited health literacy among patients, coupled
with inadequate access to accurate information,
could heighten their inabilities to make an
informed decision about medical tourism and
ultimately to accept the risks of going abroad
and providing informed consent.
Strengths and limitations of this study
▪ This article offers some of the first empirical
insights coming from health and safety profes-
sionals about medical tourism. This article identi-
fies important avenues for future research as well
as for interventions that can be implemented to
secure the safety and, ultimately, health of medical
tourists. As this is a qualitative study, others can
use the information provided herein to assess the
transferability of the findings to their own contexts.
▪ Two participants spoke more than others in the
focus group. Not all patient health and safety
domains were represented among the participants.
As this is not a quantitative study, generalisability
cannot, and should not, be accomplished.
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Medical tourism involves patients’ intentional travel to
privately obtain medical care in another country.1 2
Outﬂows of patients are reported to be increasing as
they seek more accessible, affordable or unrestricted
care elsewhere.3 4 Patients are travelling to a growing list
of international destinations to obtain an array of proce-
dures, ranging from those with low-to-high risk of com-
plication or other negative outcomes.5–11 While there
are few quantitative studies of complication rates asso-
ciated with this practice, researchers examining out-
bound medical tourism from Oman found that
15% of 45 surveyed medical tourists experienced compli-
cations following treatment abroad,12 while a survey of
the British Association of Plastic, Reconstructive and
Aesthetic Surgery found that 37% of members had seen
patients with complications resulting from medical
tourism.13 Complications are only one type of health
and safety risk to which medical tourists may be
exposed.
Various forms of risk are commonly associated with
medical tourism. Medical tourists who ﬂy abroad are
thought to be at heightened risk for deep vein throm-
bosis or pulmonary embolism owing to long-distance air
travel following surgery.14–17 There is also concern that
medical tourists are at risk of exposure to blood-borne
infection due to inadequate blood collection, screening
and storage protocols in destination countries.7 14 15 18–20
Individuals travelling for organ transplantation in particu-
lar may experience higher rates of severe infectious com-
plications because of inadequate screening protocols
abroad.4 21 22 Concern has also been raised that medical
tourists may transmit infections to their home countries,
demonstrated through the spread of New Delhi metallo-
beta-lactamase 1 (NDM 1) to the home countries of
patients who had been treated abroad.2 23
Numerous researchers express concern about the
quality of medical care available in some medical
tourism facilities, though evidence to support many of
these concerns is lacking.2 5 24 25Although some facilities
are accredited by such organisations as Joint
Commission International and Accreditation Canada,
much uncertainty exists regarding the value of accredit-
ation as an indicator of high-quality care.7 15 26
Additional concern exists about the facilities’ abilities to
meet widely acknowledged quality indicators. For
example, medical tourism can disrupt continuity of care
and result in gaps in documentation of patients’ medical
history.4 8 19 24 26–31 As a result, medical tourists may lack
adequate access to follow-up once back home owing to
documentation gaps and resulting liability concerns
held by physicians.15 17 19 31–33 Another area of quality
concern pertains to the capacity of medical tourists to
make informed decisions in the face of limited informa-
tion about hospital quality, surgical outcomes and risks
and complications.6 8–9 11 18 29 34 35
Research about medical tourism is nascent.1–2 25 36
Empirical evidence regarding health and safety risks
facing medical tourists is limited. To date, consideration
of this issue in the literature is dominated by speculation
and reports of individual cases and small case series and
lacks meaningful input from clinicians and others with
speciﬁc expertise in issues of patient health and safety.
Much of what is known about the risks potentially faced
by medical tourists comes from news media reports. For
example, a Canadian newspaper series described infec-
tions resulting from medical tourists’ pursuit of plastic
surgery abroad,9 and an American newspaper report
noted the corrective treatment required by a patient
who obtained plastic surgery abroad.10 Turner37
reviewed 26 news reports which focused on the deaths
of patients following cosmetic or bariatric surgery
abroad. Among other important ﬁndings, it was discov-
ered that medical tourists’ postoperative deaths occurred
across high-income, middle-income and low-income des-
tination nations, and not only in countries commonly
thought to have lax safety standards.
Canadian patients are known to travel to a range of
medical tourism destinations, both for procedures that
are covered in the public Medicare system (eg, ortho-
paedic surgeries) and those that are not (eg, dental
care).3 30 Recent research shows that they are often
motivated to seek medical care abroad out of a desire to
save costs on procedures not covered by Medicare,
access care faster than if they were assigned to a domes-
tic wait-list and obtain procedures that are not com-
monly available or not available at all in Canada.3
Acknowledging this outbound patient ﬂow, we held a
focus group among safety experts in the province of
British Columbia (BC) to explore their views concerning
risks that patients from the province may be exposed to
by engaging in medical tourism. This constitutes the ﬁrst
scholarly attempt to consult with this stakeholder group
about medical tourism. Herein, we report on focus
group ﬁndings, linking these empirical insights to exist-
ing ethical and legal issues associated with medical
tourism. We examine ethical and legal implications asso-
ciated with the ﬁndings for two reasons. First, there is a
growing body of ethical and legal scholarship about
medical tourism to draw upon when addressing the
practical implications of this practice.5 38–40 Second,
while participants speciﬁcally commented on the use of
medical tourism by patients from BC, Canada, engage-
ment with the wider ethics and legal literatures assists
with ‘scaling up’ the ﬁndings and demonstrating their
transferability to other home countries for medical
tourists.
METHODS
The purpose of this study was to gain the ﬁrst empirical
insights into health and safety professionals’ perspectives
on the risks of outbound medical tourism by Canadians,
with a focus on the province of BC, and to begin consid-
ering appropriate interventions to secure these patients’
health and safety. Our research team was made up of
health services, ethics and legal scholars with established
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research interests in medical tourism, as well as an inde-
pendent patient health and safety professional from BC
who served as a knowledge end-user collaborator on the
study. To accomplish our purpose, we held a focus
group in September 2011 in Vancouver, BC with profes-
sionals representing distinct domains of expertise. Prior
to undertaking this research, approval for the study was
received from the Ofﬁce of Research Ethics at Simon
Fraser University.
Recruitment
We aimed to have 6–10 representatives participate. We
use the term ‘representatives’ to indicate that participants
were invited to share their own perspectives and those of
the organisations and agencies where they worked. As
such, we sought out high-level representatives (eg, direc-
tors, managers, etc) to participate or recommend indivi-
duals from their respective organisations and agencies
who would be well suited to attend the focus group. To
begin recruiting, we ﬁrst identiﬁed distinct domains of
expertise that we wanted to be represented in the focus
group based on a review of the health and safety issues
commonly raised in medical tourism and the related
domains of professional practice, relying heavily on the
expertise of our knowledge end-user collaborator. We
then conducted online searches to identify organisations
and agencies relevant to these domains, identifying spe-
ciﬁc people who worked within them and sharing the
outcomes of these searches with our knowledge end-user
collaborator for input as well as conﬁrmation of the rela-
tive importance of potential organisations and agencies.
We next sent these individuals invitations to participate.
If unable to attend, they were asked to recommend
others with similar expertise whom we could invite. It was
explained in the invitation that participants were not
required to have extensive existing knowledge about
medical tourism.
Twenty-nine representatives were invited to participate.
Fifteen were unavailable or did not wish to participate.
Five did not respond to our invitation. Nine representa-
tives accepted our invitation. Of this cohort, two with-
drew prior to the focus group owing to changes in
availability. The domains of expertise represented by the
seven participants were tissue banking, blood safety,
health records, organ transplantation, dental care, clin-
ical ethics and infection control.
Data collection
The focus group ran for 4 h. Two facilitators guided the
conversation while a note-taker recorded observations. It
began with introductions followed by an overview of the
goals. A discussion followed, guided by the questions:
what is medical tourism and what do you think are some
of the main patient health and safety issues associated
with medical tourism. The facilitators then gave a brief
overview of the key issues discussed in the medical
tourism literature to ensure that participants were
working from a common understanding of key issues.
Participants next discussed what they understood to be
the implications of the health and safety risks they had
previously identiﬁed. The facilitators then gave another
brief overview, this time focused on published case
reports of negative health outcomes stemming from
medical tourism. A ﬁnal discussion ensued, which
focused on identifying interventions for addressing
health and safety risks.
Analysis
A digital recording of the focus group was transcribed
and thematic analysis was applied. Thematic analysis
involves identifying trends and identifying linkages
between these trends and issues identiﬁed in the exist-
ing literature.41 In undertaking analysis, we ﬁrst under-
took an independent transcript review. Following this, a
team discussion was held to identify the dominant
health and safety risks identiﬁed. After reaching consen-
sus on these risks and their scope, the data relating to
each were extracted into separate word processing ﬁles
for further review. The extracted data were then used to
shape the structure of the results section and inform our
discussion of the links between the ﬁndings and the
existing knowledge on medical tourism, with a particular
focus on the ethical and legal implications.
RESULTS
Five dominant health and safety risks for outbound
medical tourists from BC were identiﬁed: (1) complica-
tions; (2) speciﬁc concerns regarding organ transplant-
ation; (3) transmission of antibiotic-resistant organisms;
(4) (dis)continuity of medical documentation and
(5) (un)informed decision-making. In this section, we
discuss each of them separately. Verbatim quotations
from participants are italicised.
Complications
Recognising that patients can face complications when
obtaining medical care at home, participants had par-
ticular concerns about complication risk as a result of
medical procedures obtained abroad. One participant
who had seen many severe complications following
medical tourism explained that ‘when it goes wrong it
really goes wrong’. The risk of complications was
thought to be dependent on the procedure obtained
and the patient’s existing health status. For example,
several participants discussed the risks particular to
patients managing chronic disease with complex
medical histories or pharmacological regimes. It was
thought that, in these cases, there could be a greater
risk of complications: “given the demographic…many
[medical tourists]…have some chronic disease manage-
ment that they’re dealing with…and it’s like oh my God
[the risks they could face].”
Participants were concerned about the demands the
BC healthcare system faced as a result of treating compli-
cations incurred through medical tourism. They
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expressed uncertainty over “the support for them
(medical tourists) on their return and…is our health
care system then responsible for the sequelae of them
undergoing the procedure somewhere else if they
develop a complication?” Many participants had con-
cerns over the potential demands on clinicians and
health and safety professionals for providing such care.
It was also noted that medical tourists experiencing com-
plications could be embarrassed about their situation. As
a result, they might be reluctant to seek care upon
return home, increasing their risk for continued nega-
tive health outcomes. “Yeah they might be feeling really
bad and they’ve got an infection…and they’re feeling
really stupid [for going abroad] and it’s like ‘oh it might
go away, I’ll…try home remedies’ or something and by
the time they get to the medical care then it’s out of
control.” Participants expressed concern that delays in
treating complications might require additional
resources from the BC health system.
SPECIFIC CONCERNS REGARDING ORGAN
TRANSPLANTATION
Concerns emerged regarding transmission of infectious
disease via transplantation, which was raised as an issue
distinct from complications associated with other surger-
ies. Many participants expressed uncertainty regarding
the safe acquisition of organs abroad and selection cri-
teria for donors, indicating that non-industry-based infor-
mation is lacking. It was noted that “occasionally we can
know that they’re [a medical tourist is] doing this [plan-
ning to go abroad] ‘cause they announce it in advance,
and…they’re required to get vaccinated, the whole
Hepatitis range and all these things and that’s because
they’re not screening the donors [abroad].” However, in
most cases, there is no warning of a patient’s intent to go
abroad for transplantation and so there is no opportunity
to encourage vaccination before departure.
Because of the unclear organ screening standards and a
lack of information about organ provenance and infection
rates at facilities, individuals going abroad for transplant
are at risk of exposure to infectious diseases. Participants
were particularly concerned about the impacts of organ
transplant patients’ acquired infections on the BC health
system upon return home, and the potential public health
implications of infection spread. They pondered policy for-
mulation in this area, recognising that “how we deal with…
patients who may be coming back into our hospitals with
infections and…what the precautions are” are key concerns
that need to be addressed when creating domestic proto-
cols for addressing this issue.
Transmission of antibiotic-resistant organisms
Participants were aware that some medical tourists from
BC had indeed been exposed to antibiotic-resistant
organisms while abroad. This poses a risk to public
health upon return home. One participant noted that
she had “become aware of as an issue of…patients
returning from foreign countries…carrying some really
interesting bugs.” Treating patients with ‘really interest-
ing bugs’ is challenging, wherein health and safety ofﬁ-
cials need to identify unusual strains of organism that
they might not have previously encountered, which can
delay treatment.
Participants discussed the challenges of policy formu-
lation to address the risk of the spread of
antibiotic-resistant organisms locally from outbound
medical tourism. They focused on the costs of screening,
isolation and testing for antibiotic-resistant organisms
after medical tourists sought treatment upon return
home. A participant noted that “if you write a policy
that says anybody who’s been admitted to a hospital
abroad needs to be isolated when they’re brought into
your hospital, that has huge implications, and/or if you
would say ‘well I’m going to do a screening swab on
every single one of these patients whose been hospita-
lized abroad before I admit them to my hospital’, huge
lab costs.” Agreeing that effective policy responses will
be difﬁcult to create, participants stressed the important
role played by hospital infection control protocols in
BC, such as hand washing, to limit organism spread.
(Dis)continuity of medical documentation
Participants learnt from clinicians and other front-line
providers that patients returning from medical care
abroad often bring back incomplete medical records or
no documentation of the care they received. Although
some clinicians have requested results and records from
international medical providers, destination facilities
were often uncooperative. “One letter [about a patient’s
treatment abroad]…was sent to me blacked out…from a
Mexican clinic and they just said ‘how dare you ask me
for this’."” Participants suggested that limited medical
documentation provided to medical tourists could reﬂect
a low standard of care abroad, masking shortcomings.
Participants agreed that patients typically understand
it is their right to request records to bring home with
them when engaging in medical tourism. However, they
indicated that patients rarely do so, even though it
would be reasonable for them to insist: “I want to see my
chart, I want to see… I’m going back to wherever I live,
I want to take my stuff with me in case something goes
wrong.” Participants also did not believe patients had
enough health literacy to question why a destination
facility would not take their medical histories, something
they reported was common. Meanwhile, failure by clini-
cians to obtain this information can result in complica-
tions or other negative outcomes. In effect, “the
procedure [becomes] compromised…because they
[were not asked for] a health history… So it kind of
goes back to that health literacy point.”
(Un)informed decision-making
Participants discussed at length issues of informed
decision-making. They generally felt medical tourists
were uninformed about risks they may face abroad, as
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well as factors they should consider when selecting a
facility. Participants characterised uninformed decision-
making as a signiﬁcant problem among medical tourists,
particularly among those who obtained dental or cos-
metic procedures. They posited that for some patients,
the decision to obtain a procedure abroad is made with
minimal thought. “We…are really concerned that
there’s a lack of understanding [by patients] and…it’s
driven by [the appeal of low] cost.” It was also reported
that patients’ decisions to go abroad were sometimes
made hastily. Participants characterised such decision-
making as risky, in part because patients’ satisfaction is
evaluated retroactively based on outcomes. “It’s interest-
ing because their criteria for saying ‘it was a dumb deci-
sion [to have medical care abroad]’ is only based on the
consequences.”
Participants suggested that if medical tourists do not
fully understand the risks of the procedure they plan to
purchase, it is questionable whether they are in a position
to give informed consent. A participant noted that “sixty
percent of Canadians have a hard time meeting one of
the components of consent, understanding… And so a
certain assumption around their capacity to understand
[is made]…” It was suggested that patients may not know
the right questions to ask to ensure that a facility imple-
ments the correct safety controls. “Do [patients] actually
ask things like infection rates at these facilities?... We have
best practice guidelines in processing medical devices,
[but] what’s the standard in these countries?”
Participants were also concerned that patients’ decision-
making capacities may have begun to lessen in the face of
upsell messages used by facilities abroad, encouraging
them to purchase additional procedures.
DISCUSSION
The ﬁndings reveal that the representatives we spoke
with have a number of concerns regarding the risks that
can confront outbound medical tourists from BC. Many
of the risks they identiﬁed are discussed in the existing
literature. This is an important empirical ﬁnding as it
demonstrates that those with expertise in infection
control, blood safety, clinical ethics and other ﬁelds asso-
ciated with patient health and safety conﬁrm the rele-
vance of risks previously hypothesised about in the
medical tourism literature.
Some issues did not receive as much attention in the
focus group as we may have expected relative to their
coverage in the medical tourism literature. First, there
was limited discussion about the experimental proce-
dures (eg, stem cell therapies) pursued abroad and their
associated risks despite signiﬁcant coverage in the
popular and academic literatures.42 43 This may reﬂect
the participants’ limited exposure to medical tourists
who have obtained such procedures. Second, although
legal liability is often discussed in relation to risks inher-
ent in medical tourism,7 38 44 it received relatively little
consideration by the participants. Although there was no
health law representative, we expected more explicit dis-
cussion of this issue given the centrality of legal liability
to debates around medical tourism. Third, although
concern about the quality of care received abroad was
discussed, this topic received minimal attention relative
to others. This may have been because health and safety
issues are thought to be implicitly about care quality.
Fourth, although health and safety risks are sometimes
couched around larger health equity concerns and, in
particular, in destination nations,1–2 44 these concerns
did not emerge in participants’ discussions. This may
reﬂect participants’ lack of awareness of the health
equity debates that surround medical tourism.
The ﬁndings offer new insights into current debates
concerning the health and safety risks in medical tourism.
One of these pertains to participants’ identiﬁcation of
health system limitations to addressing concerns. For
example, the lack of existing protocols for treating patients
treated abroad and the prohibitively high costs of and
legal barriers to putting patients into isolation who had
acquired antibiotic-resistant organisms were identiﬁed as
limitations. Another new insight is participants’ concern
that the general lack of health literacy will lead to out-
bound medical tourists ultimately experiencing health and
safety risks, a point that broadens existing concern about
medical tourists’ lack of reliable access to third-party infor-
mation about facilities and surgeons abroad.3
Ethical and legal implications
Some issues raised by participants’ parallel legal and bio-
ethics scholars’ concerns with addressing the health
system and public health effects of individual medical
tourists’ decisions.45 46 The concern, established in tort
law, pertains to whether or not patients must assume the
full costs of their decisions so that the repercussions are
not unfairly borne by others. Such concerns are heigh-
tened in a universal healthcare system like Canada’s
where provincial/territorial budgets are ﬁxed and
health resources are shared by all.47 This egalitarian
approach to access raises the issue of fairness in relation
to addressing complications or the outcomes of other
risks experienced owing to medical tourism. This is
because Canadian citizens will be burdened by these col-
lectively imposed costs without accessing the individual
beneﬁts of engaging in medical tourism.30 This same
ethico-legal concern has been raised in other home
countries for medical tourists with public healthcare
systems, including the UK.2 44 Demonstrating an aware-
ness of this concern, participants questioned the extent
of their responsibility for addressing negative outcomes
experienced by outbound medical tourists, given these
patients’ individual decisions to access care abroad.
The potential for collective effects emerging from
individual patients’ decisions to go abroad for private
medical care emerged from participants’ discussions of
the risks of infection spread due to medical tourism.
Complications stemming from treating infections may
pose costs for the domestic healthcare system and could
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take the form of a low-probability, but high-impact, event
that would require isolating many patients or even quar-
antining a hospital. Participants expressed frustration at
the lack of good solutions to these problems at the hos-
pital level and, in particular, their inability to quaran-
tine, test or even identify all medical tourism patients.
The solutions they offered focused on infection control
measures, such as hand-washing procedures, which are
not speciﬁc to addressing the health and safety risks
posed by medical tourism in particular. They did,
however, hint at system-level reforms such as limiting
coverage for unauthorised transplant tourism or better
regulation of medical tourism facilitators (eg, licensing,
standardised training), both of which have analogues in
the legal and bioethics literatures.38 48
Patient autonomy, including through informed
consent, is a cornerstone of bioethics, and health law has
been ﬂagged as a concern for medical tourists.44 49 In the
context of medical tourism, informed consent can be dis-
rupted by misleading or incomplete information on web-
sites,36 50 difﬁculties in obtaining information about
success rates48 and the quality and standard of care in
destination facilities.38 51 Participants echoed these exist-
ing concerns, adding that the limited health literacy
among Canadians, coupled with inadequate access to
accurate information, could heighten patients’ inabilities
to make an informed decision about medical tourism and
ultimately to accept the risks of going abroad.
While obtaining informed consent for medical proce-
dures is difﬁcult under optimal considerations,52 the
international dimension of medical tourism raises special
concerns. Participants expressed that patients may not be
aware of the risks of infectious diseases contracted abroad
or that they will be unable to obtain medical records for
foreign care; more generally, it was thought that medical
tourists do not know what questions to ask to better
understand their risks or, owing to well-recognised cogni-
tive biases, fail to adequately appreciate these risks.
Participants also expressed concern that obtaining infor-
mation about the risks of speciﬁc treatments in particular
facilities would be very difﬁcult. This opacity is problem-
atic because information on whether internationally
accepted safety protocols are being followed is typically
unavailable and patients may not be aware of the need to
ask about these protocols or feel empowered to do so.
Because of the multiple jurisdictions involved and lack of
clarity in terms of which the jurisdiction’s law applies in
circumstances of medical tourism, effective legal solu-
tions to these problems are difﬁcult to establish,53
thereby placing pressure on patients’ home healthcare
systems, including health and safety professionals, to
address them in an ad hoc fashion.
Recommendations
First, there is a need for more research about health
and safety risks in medical tourism, including: quantify-
ing risk occurrence and determining which negative out-
comes are attributable to medical tourism. Second,
protocols are needed to identify patients that have
engaged in medical tourism, to treat these patients, as
well as to enable infection control and containment pro-
cedures. Similarly, increased familiarity with destination
country protocols is needed. Third, information about
the risks of engaging in medical tourism needs to be
effectively transmitted to potential medical tourists. As
suggested by the participants, this can be achieved both
by providing materials on the risks of medical tourism
and improving the public’s overall health literacy.
Finally, action needs to be taken to address participants’
and others’ (eg, 25) concerns about discontinuities in
medical documentation for medical tourists. For
example, consideration could be given to developing a
template that destination country physicians complete as
a precondition of treatment.
Study limitations
First, a limitation of focus groups is that particular indivi-
duals may dominate.54 Although we encouraged all par-
ticipants to engage in talk, two spoke most often.
Second, we are aware that some health and safety
domains were not represented. For example, there was
no care quality representative or individual from the
province’s Ministry of Health despite efforts to recruit
both. Third, reliance on a single focus group with parti-
cipants in BC limits generalisability. However, as this is a
qualitative study, generalisability is not a goal.55 Instead,
we seek transferability, accomplishing this by providing
details others need to assess the relevance of the ﬁnd-
ings to their speciﬁc contexts.
CONCLUSION
We spoke with seven BC-based participants with consider-
able expertise in key patient health and safety domains.
Participants identiﬁed ﬁve main health and safety risks
associated with outbound medical tourism by BC
patients. Concern was expressed that medical tourism
might have unintended and undesired effects upon pro-
vincial/territorial healthcare systems. In particular, parti-
cipants noted that individual choices of medical tourists
could have signiﬁcant public consequences if domestic
healthcare facilities must expend resources treating post-
operative complications of medical tourists. They also
expressed concern that medical tourists returning home
with infections, particularly antibiotic-resistant infections,
could place healthcare providers such as themselves and
other patients at risk of exposure to infections that are
refractory to standard treatment regimens and pose sig-
niﬁcant risks. There was considerable uncertainty over
how such risks should be addressed and mitigated. This
uncertainty suggests that clinicians, patients, healthcare
administrators and other involved parties are likely to
gain from a public dialogue about developing policy
responses to both the risks and beneﬁts associated with
medical tourism, not only within Canada but in all coun-
tries facing outﬂows of medical tourists.
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